PhysiologyBioorganic ChemistryPeer-reviewed
Targeting Tenascin-C-Toll-like Receptor 4 signalling with Adhiron-derived small molecules - a viable strategy for reducing fibrosis in Systemic Sclerosis
Thembaninkosi G. Gaule, Katie J. Simmons, Kieran Walker…·Azhar Maqbool
This paper identifies small molecules targeting the Tenascin C fibrinogen-like globe domain to reduce fibrosis in systemic sclerosis by inhibiting Toll-like receptor 4 signaling.
2 citations